» Articles » PMID: 39769997

Vibrational and DFT Studies and Anticancer Activity of Novel Pd(II) and Pt(II) Complexes with Chloro Derivatives of 7-Azaindole-3-Carbaldehyde

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2025 Jan 8
PMID 39769997
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigates the structural, vibrational, and biological properties of novel palladium(II) and platinum(II) complexes with 5-chloro-7-azaindole-3-carbaldehyde (5ClL) and 4-chloro-7-azaindole-3-carbaldehyde (4ClL) ligands. Infrared and Raman spectroscopy, combined with DFT (ωB97X-D) calculations, provided valuable information about metal-ligand interactions, the or conformation of the aldehyde group in the ligands, and the presence of isomers in the metal complexes obtained in the solid state. tests were used to evaluate the antiproliferative activity of the novel complexes against several cancer cell lines, including ovarian cancer (A2780), cisplatin-resistant ovarian cancer (A2780cis), colon cancer (HT-29), and triple-negative breast cancer (MDA-MB-231), as well as normal mouse fibroblasts (BALB/3T3). The platinum complex, -[PtCl(5ClL)], exhibited superior activity against A2780cis (IC = 4.96 ± 0.49 µM) and MDA-MB-231 (IC = 4.83 ± 0.38 µM) compared to cisplatin, while the palladium complexes (-[PdCl(4ClL)] and -[PdCl(5ClL)]) demonstrated enhanced selectivity with reduced toxicity to normal fibroblasts (IC = 11.29 ± 6.65 µM and 14.98 ± 5.59 µM, respectively).

References
1.
Zhou M, Boulos J, Omer E, Rudbari H, Schirmeister T, Micale N . Two palladium (II) complexes derived from halogen-substituted Schiff bases and 2-picolylamine induce parthanatos-type cell death in sensitive and multi-drug resistant CCRF-CEM leukemia cells. Eur J Pharmacol. 2023; 956:175980. DOI: 10.1016/j.ejphar.2023.175980. View

2.
Muchova T, Pracharova J, Starha P, Olivova R, Vrana O, Benesova B . Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells. J Biol Inorg Chem. 2013; 18(5):579-89. DOI: 10.1007/s00775-013-1003-7. View

3.
Johnstone T, Suntharalingam K, Lippard S . The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev. 2016; 116(5):3436-86. PMC: 4792284. DOI: 10.1021/acs.chemrev.5b00597. View

4.
Lazarevic T, Rilak A, Bugarcic Z . Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem. 2017; 142:8-31. DOI: 10.1016/j.ejmech.2017.04.007. View

5.
Han R, Ketkaew R, Luber S . A Concise Review on Recent Developments of Machine Learning for the Prediction of Vibrational Spectra. J Phys Chem A. 2022; 126(6):801-812. DOI: 10.1021/acs.jpca.1c10417. View